CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 6:00 PM ISTNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
Synokem Pharmaceuticals gets CDSCO panel nod to conduct phase III CT of FDC Salicylic Acid plus Luliconazole Dr. Divya Colin22 Jan 2023 4:15 PM ISTNew Delhi: Drug major, Synokem Pharmaceutical has got approval from the Subject Expert Panel (SEC) functional under the Central Drug Standard Control...
Synokem Pharama gets CDSCO panel nod to manufacture, market Naftifine HCL Cream 2% Dr. Divya Colin22 Dec 2022 6:00 PM ISTNew Delhi: The drug major Synokem Pharmaceutical has got green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
59 Drug Samples Including Cadila pharma Aciloc 150 Fail To Qualify CDSCO Test Susmita Roy18 Oct 2022 6:00 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 59 medicine...
CDSCO panel rejects Synokem Pharma proposal for oral antidiabetic drug Imeglimin Medical Dialogues Team19 Nov 2021 8:14 PM ISTNew Delhi: Rejecting the drug major Synokem Pharma's proposal for oral anti-diabetic medication Imeglimin 500mg and 1000mg Tab, the Subject Expert...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Mankind Pharma Medical Dialogues Team25 Jun 2021 5:22 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, Dapagliflozin to consumers, the National Pharmaceutical Pricing...
